Ardelyx, Inc. (ARDX) Financials

ARDX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 297.6 million 130.8 million
2023-09-30 289.4 million 98.2 million
2023-06-30 211.2 million 88.0 million
2023-03-31 217.0 million 91.6 million

ARDX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -8.8 million 3.9 million
2023-09-30 -21.7 million 3.5 million
2023-06-30 -14.8 million 3.2 million
2023-03-31 -44.8 million 2.9 million

ARDX Net Income

No data available :(

ARDX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 184.3 million - 6.2 million
2023-09-30 165.1 million - 7.2 million
2023-06-30 127.6 million - 7.9 million
2023-03-31 130.4 million - 8.8 million

ARDX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 219.3 million
2023-09-30 227.9 million
2023-06-30 215.0 million
2023-03-31 207.0 million

ARDX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 43000 9.5 million 47.7 million -
2023-09-30 194000 8.6 million 32.7 million -
2023-06-30 93000 8.3 million 27.2 million -
2023-03-31 14000 9.1 million 26.8 million -

ARDX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 34.4 million 5.1 million
2023-09-30 56.4 million 7.0 million
2023-06-30 22.3 million 3.5 million
2023-03-31 11.4 million 1.5 million

ARDX

Price: $8.72

52 week price:
3.16
10.13

Earnings Per Share: -0.30 USD

P/E Ratio: -148.17

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 8.1 million

Ebitda: -20.5 million

Market Capitalization: 1.6 billion

Links: